The markets for anesthesia disposables, delivery units and monitors, along with the nebulizer and ventilator markets, are set to demonstrate lower levels of growth than other sectors. These markets are saturated with capital equipment and disposables and are growing only marginally alongside the growth in procedures and innovating new features. On the other hand, the markets for therapeutic sleep management devices and oxygen therapy devices are set to grow over the forecast period. In addition to technological innovation, these markets are set to improve as a result of increasing diagnoses through rising patient awareness.
This anesthesia, respiratory and sleep apnea market includes analysis for anesthesia delivery units (ADUs), anesthesia patient monitors, anesthesia information management systems (AIMS), anesthesia disposables, ventilators, nebulizers, respiratory disposables, oxygen therapy devices, therapeutic obstructive sleep apnea (sleep therapy) devices and sleep diagnostic devices.
This anesthesia, respiratory and sleep apnea market includes analysis for anesthesia delivery units (ADUs), anesthesia patient monitors, anesthesia information management systems (AIMS), anesthesia disposables, ventilators, nebulizers, respiratory disposables, oxygen therapy devices, therapeutic obstructive sleep apnea (sleep therapy) devices and sleep diagnostic devices.
Table of Contents
TABLE OF CONTENTSLIST OF FIGURESLIST OF CHARTS15. ABBREVIATIONS
1. EXECUTIVE SUMMARY
U.S. ANESTHESIA, RESPIRATORY AND SLEEP MANAGEMENT DEVICE MARKET OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
MARKETS INCLUDED
KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
MARKETS INCLUDED
KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
2. DISEASE OVERVIEW
2.1 BASIC ANATOMY
2.1.1 Respiratory System
2.2 DISEASE TREATMENTS & DIAGNOSTICS
2.2.1 Chronic Obstructive Pulmonary Disease
2.2.2 Sleep Apnea
2.2.2.1 OSA
2.3 PATIENT DEMOGRAPHICS
2.3.1 COPD Incidence
2.3.2 OSA Incidence
2.1.1 Respiratory System
2.2 DISEASE TREATMENTS & DIAGNOSTICS
2.2.1 Chronic Obstructive Pulmonary Disease
2.2.2 Sleep Apnea
2.2.2.1 OSA
2.3 PATIENT DEMOGRAPHICS
2.3.1 COPD Incidence
2.3.2 OSA Incidence
3. PRODUCT ASSESSMENT
3.1 INTRODUCTION
3.2 PRODUCT PORTFOLIOS
3.2.1 Anesthesia Delivery Unit
3.2.2 Anesthesia Monitor
3.2.3 Anesthesia Disposables
3.2.3.1 Anesthesia Circuits
3.2.3.2 Anesthesia Masks
3.2.3.3 Endotracheal Tubes
3.2.3.4 Laryngeal Masks
3.2.4 Ventilators
3.2.4.1 Acute care Ventilators
3.2.4.2 Sub-Acute Ventilators
3.2.4.3 Home Care Ventilators
3.2.4.4 Neonatal Ventilators
3.2.4.5 Non-Invasive Ventilators
3.2.5 Nebulizers
3.2.6 Respiratory Disposables
3.2.6.1 Oxygen Cannula
3.2.6.2 Oxygen Masks
3.2.6.3 Tracheostomy Tubes
3.2.6.4 Resuscitators
3.2.7 Oxygen Therapy
3.2.7.1 Compressed Gas Cylinders
3.2.7.2 Oxygen Concentrators
3.2.7.3 Transfilling Devices
3.2.7.4 Regulators
3.2.7.5 Conservers
3.2.7.6 Liquid Oxygen
3.2.8 Therapeutic Sleep Management
3.2.9 Sleep Diagnostic Devices
3.2.9.1 Type I Sleep Test
3.2.9.2 Type II Sleep Test
3.2.9.3 Type III Sleep Test
3.2.9.4 Type IV Sleep Test
3.3 REGULATORY ISSUES AND RECALLS
3.3.1 Dr?ger
3.3.1.1 Anesthesia Delivery Unit
3.3.1.2 Anesthesia Information Management System
3.3.1.3 Ventilator
3.3.2 DeVilbiss
3.3.2.1 Therapeutic Obstructive Sleep Apnea
3.3.3 Fisher & Paykel
3.3.3.1 Therapeutic Obstructive Sleep Apnea
3.3.4 GE Healthcare
3.3.4.1 Anesthesia Delivery Unit
3.3.4.2 Anesthesia Monitor
3.3.5 Invacare
3.3.5.1 Oxygen Therapy
3.3.6 Medtronic
3.3.6.1 Respiratory Disposables
3.3.7 Philips
3.3.7.1 Anesthesia Monitor
3.3.7.2 Anesthesia Information Management System
3.3.7.3 Ventilator
3.3.7.4 Nebulizer
3.3.8 ResMed
3.3.8.1 Ventilator
3.3.8.2 Therapeutic Obstructive Sleep Apnea
3.3.9 Teleflex
3.3.9.1 Anesthesia Disposables
3.3.9.2 Respiratory Disposables
3.3.10 Vyaire Medical
3.3.10.1 Anesthesia Disposables
3.3.10.2 Ventilator
3.4 CLINICAL TRIALS
3.4.1 Chart Industries
3.4.1.1 Oxygen Therapy
3.4.2 Dr?ger
3.4.2.1 Anesthesia Delivery Unit
3.4.2.2 Ventilator
3.4.3 DeVilbiss
3.4.3.1 Nebulizer
3.4.3.2 Therapeutic Obstructive Sleep Apnea
3.4.4 Fisher & Paykel
3.4.4.1 Therapeutic Obstructive Sleep Apnea
3.4.5 GE Healthcare
3.4.5.1 Anesthesia Delivery Unit
3.4.5.2 Anesthesia Monitor
3.4.5.3 Anesthesia Information Management System
3.4.6 Invacare
3.4.6.1 Oxygen Therapy
3.4.7 Medtronic
3.4.7.1 Anesthesia Disposables
3.4.8 Natus
3.4.8.1 Sleep Diagnostic Devices
3.4.9 Philips
3.4.9.1 Anesthesia Monitor
3.4.9.2 Ventilator
3.4.9.3 Nebulizer
3.4.9.4 Oxygen Therapy
3.4.9.5 Therapeutic Obstructive Sleep Apnea
3.4.9.6 Sleep Diagnostic Devices
3.4.10 ResMed
3.4.10.1 Ventilator
3.4.10.2 Therapeutic Obstructive Sleep Apnea
3.4.10.3 Sleep Diagnostic Devices
3.4.11 Teleflex
3.4.11.1 Anesthesia Disposables
3.4.11.2 Respiratory Disposables
3.4.12 Vyaire Medical
3.4.12.1 Ventilator
3.4.12.2 Nebulizer
3.4.12.3 Respiratory Disposables
3.2 PRODUCT PORTFOLIOS
3.2.1 Anesthesia Delivery Unit
3.2.2 Anesthesia Monitor
3.2.3 Anesthesia Disposables
3.2.3.1 Anesthesia Circuits
3.2.3.2 Anesthesia Masks
3.2.3.3 Endotracheal Tubes
3.2.3.4 Laryngeal Masks
3.2.4 Ventilators
3.2.4.1 Acute care Ventilators
3.2.4.2 Sub-Acute Ventilators
3.2.4.3 Home Care Ventilators
3.2.4.4 Neonatal Ventilators
3.2.4.5 Non-Invasive Ventilators
3.2.5 Nebulizers
3.2.6 Respiratory Disposables
3.2.6.1 Oxygen Cannula
3.2.6.2 Oxygen Masks
3.2.6.3 Tracheostomy Tubes
3.2.6.4 Resuscitators
3.2.7 Oxygen Therapy
3.2.7.1 Compressed Gas Cylinders
3.2.7.2 Oxygen Concentrators
3.2.7.3 Transfilling Devices
3.2.7.4 Regulators
3.2.7.5 Conservers
3.2.7.6 Liquid Oxygen
3.2.8 Therapeutic Sleep Management
3.2.9 Sleep Diagnostic Devices
3.2.9.1 Type I Sleep Test
3.2.9.2 Type II Sleep Test
3.2.9.3 Type III Sleep Test
3.2.9.4 Type IV Sleep Test
3.3 REGULATORY ISSUES AND RECALLS
3.3.1 Dr?ger
3.3.1.1 Anesthesia Delivery Unit
3.3.1.2 Anesthesia Information Management System
3.3.1.3 Ventilator
3.3.2 DeVilbiss
3.3.2.1 Therapeutic Obstructive Sleep Apnea
3.3.3 Fisher & Paykel
3.3.3.1 Therapeutic Obstructive Sleep Apnea
3.3.4 GE Healthcare
3.3.4.1 Anesthesia Delivery Unit
3.3.4.2 Anesthesia Monitor
3.3.5 Invacare
3.3.5.1 Oxygen Therapy
3.3.6 Medtronic
3.3.6.1 Respiratory Disposables
3.3.7 Philips
3.3.7.1 Anesthesia Monitor
3.3.7.2 Anesthesia Information Management System
3.3.7.3 Ventilator
3.3.7.4 Nebulizer
3.3.8 ResMed
3.3.8.1 Ventilator
3.3.8.2 Therapeutic Obstructive Sleep Apnea
3.3.9 Teleflex
3.3.9.1 Anesthesia Disposables
3.3.9.2 Respiratory Disposables
3.3.10 Vyaire Medical
3.3.10.1 Anesthesia Disposables
3.3.10.2 Ventilator
3.4 CLINICAL TRIALS
3.4.1 Chart Industries
3.4.1.1 Oxygen Therapy
3.4.2 Dr?ger
3.4.2.1 Anesthesia Delivery Unit
3.4.2.2 Ventilator
3.4.3 DeVilbiss
3.4.3.1 Nebulizer
3.4.3.2 Therapeutic Obstructive Sleep Apnea
3.4.4 Fisher & Paykel
3.4.4.1 Therapeutic Obstructive Sleep Apnea
3.4.5 GE Healthcare
3.4.5.1 Anesthesia Delivery Unit
3.4.5.2 Anesthesia Monitor
3.4.5.3 Anesthesia Information Management System
3.4.6 Invacare
3.4.6.1 Oxygen Therapy
3.4.7 Medtronic
3.4.7.1 Anesthesia Disposables
3.4.8 Natus
3.4.8.1 Sleep Diagnostic Devices
3.4.9 Philips
3.4.9.1 Anesthesia Monitor
3.4.9.2 Ventilator
3.4.9.3 Nebulizer
3.4.9.4 Oxygen Therapy
3.4.9.5 Therapeutic Obstructive Sleep Apnea
3.4.9.6 Sleep Diagnostic Devices
3.4.10 ResMed
3.4.10.1 Ventilator
3.4.10.2 Therapeutic Obstructive Sleep Apnea
3.4.10.3 Sleep Diagnostic Devices
3.4.11 Teleflex
3.4.11.1 Anesthesia Disposables
3.4.11.2 Respiratory Disposables
3.4.12 Vyaire Medical
3.4.12.1 Ventilator
3.4.12.2 Nebulizer
3.4.12.3 Respiratory Disposables
4. U.S. ANESTHESIA, RESPIRATORY AND SLEEP MANAGEMENT DEVICE MARKET OVERVIEW
4.1 INTRODUCTION
4.1.1 Related Diseases and Conditions
4.1.1.1 Chronic Obstructive Pulmonary Disease (COPD)
4.1.1.2 Obstructive Sleep Apnea (OSA)
4.2 MARKET OVERVIEW
4.3 TREND ANALYSIS BY SEGMENT
4.4 DRIVERS AND LIMITERS
4.4.1 Market Drivers
4.4.2 Market Limiters
4.5 COMPETITIVE MARKET SHARE ANALYSIS
4.6 MERGERS AND ACQUISITIONS
4.7 COMPANY PROFILES
4.7.1 Chart Industries
4.7.2 Dr?ger
4.7.3 DeVilbiss
4.7.4 Fisher & Paykel
4.7.5 GE Healthcare
4.7.6 Invacare
4.7.7 Medtronic
4.7.8 Natus
4.7.9 Omron
4.7.10 Philips
4.7.11 ResMed
4.7.12 Teleflex
4.7.13 Vyaire Medical
4.8 SWOT ANALYSIS
4.8.1 Chart Industries
4.8.2 Dr?ger
4.8.3 DeVilbiss
4.8.4 Fisher & Paykel
4.8.5 GE Healthcare
4.8.6 Invacare
4.8.7 Medtronic
4.8.8 Natus
4.8.9 Omron
4.8.10 Philips
4.8.11 ResMed
4.8.12 Teleflex
4.8.13 Vyaire Medical
4.1.1 Related Diseases and Conditions
4.1.1.1 Chronic Obstructive Pulmonary Disease (COPD)
4.1.1.2 Obstructive Sleep Apnea (OSA)
4.2 MARKET OVERVIEW
4.3 TREND ANALYSIS BY SEGMENT
4.4 DRIVERS AND LIMITERS
4.4.1 Market Drivers
4.4.2 Market Limiters
4.5 COMPETITIVE MARKET SHARE ANALYSIS
4.6 MERGERS AND ACQUISITIONS
4.7 COMPANY PROFILES
4.7.1 Chart Industries
4.7.2 Dr?ger
4.7.3 DeVilbiss
4.7.4 Fisher & Paykel
4.7.5 GE Healthcare
4.7.6 Invacare
4.7.7 Medtronic
4.7.8 Natus
4.7.9 Omron
4.7.10 Philips
4.7.11 ResMed
4.7.12 Teleflex
4.7.13 Vyaire Medical
4.8 SWOT ANALYSIS
4.8.1 Chart Industries
4.8.2 Dr?ger
4.8.3 DeVilbiss
4.8.4 Fisher & Paykel
4.8.5 GE Healthcare
4.8.6 Invacare
4.8.7 Medtronic
4.8.8 Natus
4.8.9 Omron
4.8.10 Philips
4.8.11 ResMed
4.8.12 Teleflex
4.8.13 Vyaire Medical
5. ANESTHESIA DELIVERY UNIT MARKET
5.1 INTRODUCTION
5.1.1 Anesthesia Delivery Unit Classification
5.2 MARKET OVERVIEW
5.3 MARKET ANALYSIS AND FORECAST
5.3.1 Total Anesthesia Delivery Unit Market
5.3.2 Total Hospital OR ADU Market
5.3.2.1 High-Complexity Hospital OR ADU Market
5.3.2.2 Low-Complexity Hospital OR ADU Market
5.3.3 Total Other Hospital Suite ADU Market
5.3.3.1 MRI Suite ADU Market
5.3.3.2 Obstetric Suite ADU Market
5.3.3.3 Other/Alternate Suite ADU Market
5.3.4 Ambulatory Surgery Center ADU Market
5.3.4.1 New and Refurbished ADUs in the ASC
5.4 INSTALLED BASE ANALYSIS
5.5 DRIVERS AND LIMITERS
5.5.1 Market Drivers
5.5.2 Market Limiters
5.6 COMPETITIVE MARKET SHARE ANALYSIS
5.1.1 Anesthesia Delivery Unit Classification
5.2 MARKET OVERVIEW
5.3 MARKET ANALYSIS AND FORECAST
5.3.1 Total Anesthesia Delivery Unit Market
5.3.2 Total Hospital OR ADU Market
5.3.2.1 High-Complexity Hospital OR ADU Market
5.3.2.2 Low-Complexity Hospital OR ADU Market
5.3.3 Total Other Hospital Suite ADU Market
5.3.3.1 MRI Suite ADU Market
5.3.3.2 Obstetric Suite ADU Market
5.3.3.3 Other/Alternate Suite ADU Market
5.3.4 Ambulatory Surgery Center ADU Market
5.3.4.1 New and Refurbished ADUs in the ASC
5.4 INSTALLED BASE ANALYSIS
5.5 DRIVERS AND LIMITERS
5.5.1 Market Drivers
5.5.2 Market Limiters
5.6 COMPETITIVE MARKET SHARE ANALYSIS
6. ANESTHESIA MONITOR MARKET
6.1 INTRODUCTION
6.2 MARKET OVERVIEW
6.3 MARKET ANALYSIS AND FORECAST
6.3.1 Total Hospital Anesthesia Monitor Market
6.3.1.1 Hospital Preoperative Anesthesia Monitor Market
6.3.1.2 Hospital OR Anesthesia Monitor Market
6.3.1.3 Hospital Post-Anesthesia Care Unit Anesthesia Monitor Market
6.3.1.4 Hospital Obstetric Anesthesia Monitor Market
6.3.2 Total Ambulatory Surgery Center Anesthesia Monitor Market
6.3.2.1 ASC Preoperative Anesthesia Monitor Market
6.3.2.2 ASC OR Anesthesia Monitor Market
6.3.2.3 ASC Post-Anesthesia Care Unit Anesthesia Monitor Market
6.4 DRIVERS AND LIMITERS
6.4.1 Market Drivers
6.4.2 Market Limiters
6.5 COMPETITIVE MARKET SHARE ANALYSIS
6.2 MARKET OVERVIEW
6.3 MARKET ANALYSIS AND FORECAST
6.3.1 Total Hospital Anesthesia Monitor Market
6.3.1.1 Hospital Preoperative Anesthesia Monitor Market
6.3.1.2 Hospital OR Anesthesia Monitor Market
6.3.1.3 Hospital Post-Anesthesia Care Unit Anesthesia Monitor Market
6.3.1.4 Hospital Obstetric Anesthesia Monitor Market
6.3.2 Total Ambulatory Surgery Center Anesthesia Monitor Market
6.3.2.1 ASC Preoperative Anesthesia Monitor Market
6.3.2.2 ASC OR Anesthesia Monitor Market
6.3.2.3 ASC Post-Anesthesia Care Unit Anesthesia Monitor Market
6.4 DRIVERS AND LIMITERS
6.4.1 Market Drivers
6.4.2 Market Limiters
6.5 COMPETITIVE MARKET SHARE ANALYSIS
7. ANESTHESIA INFORMATION MANAGEMENT SYSTEM MARKET
7.1 INTRODUCTION
7.2 MARKET OVERVIEW
7.3 MARKET ANALYSIS AND FORECAST
7.3.1 Total Anesthesia Information Management System Market
7.3.2 Hospital AIMS Market
7.3.3 Ambulatory Surgery Center AIMS Market
7.4 DRIVERS AND LIMITERS
7.4.1 Market Drivers
7.4.2 Market Limiters
7.5 COMPETITIVE MARKET SHARE ANALYSIS
7.2 MARKET OVERVIEW
7.3 MARKET ANALYSIS AND FORECAST
7.3.1 Total Anesthesia Information Management System Market
7.3.2 Hospital AIMS Market
7.3.3 Ambulatory Surgery Center AIMS Market
7.4 DRIVERS AND LIMITERS
7.4.1 Market Drivers
7.4.2 Market Limiters
7.5 COMPETITIVE MARKET SHARE ANALYSIS
8. ANESTHESIA DISPOSABLES MARKET
8.1 INTRODUCTION
8.1.1 Anesthesia Circuits
8.1.2 Anesthesia Masks
8.1.3 Endotracheal Tubes
8.1.4 Laryngeal Masks
8.2 MARKET OVERVIEW
8.3 MARKET ANALYSIS AND FORECAST
8.3.1 Anesthesia Circuit Market
8.3.2 Anesthesia Mask Market
8.3.3 Sample Line Market
8.3.4 Filter/HME Market
8.3.5 Breathing Bag Market
8.3.6 Endotracheal Tube Market
8.3.7 Total Laryngeal Mask Market
8.3.7.1 Disposable Laryngeal Mask Market
8.3.7.2 Reusable Laryngeal Mask Market
8.4 DRIVERS AND LIMITERS
8.4.1 Market Drivers
8.4.2 Market Limiters
8.5 COMPETITIVE MARKET SHARE ANALYSIS
8.1.1 Anesthesia Circuits
8.1.2 Anesthesia Masks
8.1.3 Endotracheal Tubes
8.1.4 Laryngeal Masks
8.2 MARKET OVERVIEW
8.3 MARKET ANALYSIS AND FORECAST
8.3.1 Anesthesia Circuit Market
8.3.2 Anesthesia Mask Market
8.3.3 Sample Line Market
8.3.4 Filter/HME Market
8.3.5 Breathing Bag Market
8.3.6 Endotracheal Tube Market
8.3.7 Total Laryngeal Mask Market
8.3.7.1 Disposable Laryngeal Mask Market
8.3.7.2 Reusable Laryngeal Mask Market
8.4 DRIVERS AND LIMITERS
8.4.1 Market Drivers
8.4.2 Market Limiters
8.5 COMPETITIVE MARKET SHARE ANALYSIS
9. VENTILATOR MARKET
9.1 INTRODUCTION
9.1.1 Acute-Care Ventilators
9.1.2 Sub-Acute Ventilators
9.1.3 Home Care Ventilators
9.1.4 Neonatal Ventilators
9.1.5 Non-Invasive Ventilators
9.2 MARKET OVERVIEW
9.3 MARKET ANALYSIS AND FORECAST
9.3.1 Acute Care Ventilator Market
9.3.2 Sub-Acute Ventilator Market
9.3.3 Home Care Ventilator Market
9.3.4 Total Neonatal Ventilator Market
9.3.4.1 Dedicated Neonatal Ventilator Market
9.3.4.2 High-Frequency Neonatal Ventilator Market
9.3.5 Non-Invasive Ventilator Market
9.4 DRIVERS AND LIMITERS
9.4.1 Market Drivers
9.4.2 Market Limiters
9.5 COMPETITIVE MARKET SHARE ANALYSIS
9.1.1 Acute-Care Ventilators
9.1.2 Sub-Acute Ventilators
9.1.3 Home Care Ventilators
9.1.4 Neonatal Ventilators
9.1.5 Non-Invasive Ventilators
9.2 MARKET OVERVIEW
9.3 MARKET ANALYSIS AND FORECAST
9.3.1 Acute Care Ventilator Market
9.3.2 Sub-Acute Ventilator Market
9.3.3 Home Care Ventilator Market
9.3.4 Total Neonatal Ventilator Market
9.3.4.1 Dedicated Neonatal Ventilator Market
9.3.4.2 High-Frequency Neonatal Ventilator Market
9.3.5 Non-Invasive Ventilator Market
9.4 DRIVERS AND LIMITERS
9.4.1 Market Drivers
9.4.2 Market Limiters
9.5 COMPETITIVE MARKET SHARE ANALYSIS
10. NEBULIZER MARKET
10.1 INTRODUCTION
10.2 MARKET OVERVIEW
10.3 MARKET ANALYSIS AND FORECAST
10.3.1 Total Compressor/Jet Nebulizer Market
10.3.1.1 Stationary Compressor/Jet Nebulizer Market
10.3.1.2 Portable Compressor/Jet Nebulizer Market
10.3.2 Total Vibrating Nebulizer Market
10.3.2.1 Ultrasonic Nebulizer Market
10.3.2.2 Vibrating Mesh Nebulizer Market
10.4 DRIVERS AND LIMITERS
10.4.1 Market Drivers
10.4.2 Market Limiters
10.5 COMPETITIVE MARKET SHARE ANALYSIS
10.2 MARKET OVERVIEW
10.3 MARKET ANALYSIS AND FORECAST
10.3.1 Total Compressor/Jet Nebulizer Market
10.3.1.1 Stationary Compressor/Jet Nebulizer Market
10.3.1.2 Portable Compressor/Jet Nebulizer Market
10.3.2 Total Vibrating Nebulizer Market
10.3.2.1 Ultrasonic Nebulizer Market
10.3.2.2 Vibrating Mesh Nebulizer Market
10.4 DRIVERS AND LIMITERS
10.4.1 Market Drivers
10.4.2 Market Limiters
10.5 COMPETITIVE MARKET SHARE ANALYSIS
11. RESPIRATORY DISPOSABLES MARKET
11.1 INTRODUCTION
11.1.1 Oxygen Cannula
11.1.2 Oxygen Masks
11.1.3 Tracheostomy Tubes
11.1.4 Resuscitators
11.2 MARKET OVERVIEW
11.3 MARKET ANALYSIS AND FORECAST
11.3.1 Oxygen Cannula Market
11.3.2 Oxygen Mask Market
11.3.3 Tracheostomy Tube Market
11.3.4 Resuscitator Market
11.4 DRIVERS AND LIMITERS
11.4.1 Market Drivers
11.4.2 Market Limiters
11.5 COMPETITIVE MARKET SHARE ANALYSIS
11.1.1 Oxygen Cannula
11.1.2 Oxygen Masks
11.1.3 Tracheostomy Tubes
11.1.4 Resuscitators
11.2 MARKET OVERVIEW
11.3 MARKET ANALYSIS AND FORECAST
11.3.1 Oxygen Cannula Market
11.3.2 Oxygen Mask Market
11.3.3 Tracheostomy Tube Market
11.3.4 Resuscitator Market
11.4 DRIVERS AND LIMITERS
11.4.1 Market Drivers
11.4.2 Market Limiters
11.5 COMPETITIVE MARKET SHARE ANALYSIS
12. OXYGEN THERAPY MARKET
12.1 INTRODUCTION
12.1.1 Compressed Gas Cylinders
12.1.2 Oxygen Concentrators
12.1.3 Transfilling Devices
12.1.4 Regulators
12.1.5 Conservers
12.1.6 Liquid Oxygen
12.2 MARKET OVERVIEW
12.3 MARKET ANALYSIS AND FORECAST
12.3.1 Total Oxygen Concentrator Market
12.3.1.1 Stationary Oxygen Concentrator Market
12.3.1.1.1 Standard Stationary Oxygen Concentrator Market
12.3.1.1.2 High-Flow Stationary Oxygen Concentrator Market
12.3.1.2 Ambulatory Oxygen Concentrator Market
12.3.1.2.1 Transportable Oxygen Concentrator Market
12.3.1.2.2 Portable Oxygen Concentrator Market
12.3.2 Transfilling Device Market
12.3.3 Aluminum Medical Oxygen Cylinder Market
12.3.3.1 Ambulatory Aluminum Medical Oxygen Cylinder Market
12.3.3.2 Backup Aluminum Medical Oxygen Cylinder Market
12.3.4 Medical Oxygen Regulator Home Care Market
12.3.5 Oxygen Conserver Market
12.3.5.1 Pneumatic Oxygen Conserver Market
12.3.5.2 Electronic Oxygen Conserver Market
12.4 DRIVERS AND LIMITERS
12.4.1 Market Drivers
12.4.2 Market Limiters
12.5 COMPETITIVE MARKET SHARE ANALYSIS
12.1.1 Compressed Gas Cylinders
12.1.2 Oxygen Concentrators
12.1.3 Transfilling Devices
12.1.4 Regulators
12.1.5 Conservers
12.1.6 Liquid Oxygen
12.2 MARKET OVERVIEW
12.3 MARKET ANALYSIS AND FORECAST
12.3.1 Total Oxygen Concentrator Market
12.3.1.1 Stationary Oxygen Concentrator Market
12.3.1.1.1 Standard Stationary Oxygen Concentrator Market
12.3.1.1.2 High-Flow Stationary Oxygen Concentrator Market
12.3.1.2 Ambulatory Oxygen Concentrator Market
12.3.1.2.1 Transportable Oxygen Concentrator Market
12.3.1.2.2 Portable Oxygen Concentrator Market
12.3.2 Transfilling Device Market
12.3.3 Aluminum Medical Oxygen Cylinder Market
12.3.3.1 Ambulatory Aluminum Medical Oxygen Cylinder Market
12.3.3.2 Backup Aluminum Medical Oxygen Cylinder Market
12.3.4 Medical Oxygen Regulator Home Care Market
12.3.5 Oxygen Conserver Market
12.3.5.1 Pneumatic Oxygen Conserver Market
12.3.5.2 Electronic Oxygen Conserver Market
12.4 DRIVERS AND LIMITERS
12.4.1 Market Drivers
12.4.2 Market Limiters
12.5 COMPETITIVE MARKET SHARE ANALYSIS
13. THERAPEUTIC OBSTRUCTIVE SLEEP APNEA DEVICE MARKET
13.1 INTRODUCTION
13.2 MARKET OVERVIEW
13.3 MARKET ANALYSIS AND FORECAST
13.3.1 Total Positive Airway Pressure Device Market
13.3.1.1 Continuous Positive Airway Pressure Device Market
13.3.1.2 Auto-Titrating Positive Airway Pressure Device Market
13.3.1.3 Bi-Level Positive Airway Pressure Device Market
13.3.2 Total Sleep Therapy Interface Market
13.3.2.1 Nasal Mask Market
13.3.2.2 Full-Face Mask Market
13.3.2.3 Nasal Pillow/Alternative Interface Market
13.4 DRIVERS AND LIMITERS
13.4.1 Market Drivers
13.4.2 Market Limiters
13.5 COMPETITIVE MARKET SHARE ANALYSIS
13.2 MARKET OVERVIEW
13.3 MARKET ANALYSIS AND FORECAST
13.3.1 Total Positive Airway Pressure Device Market
13.3.1.1 Continuous Positive Airway Pressure Device Market
13.3.1.2 Auto-Titrating Positive Airway Pressure Device Market
13.3.1.3 Bi-Level Positive Airway Pressure Device Market
13.3.2 Total Sleep Therapy Interface Market
13.3.2.1 Nasal Mask Market
13.3.2.2 Full-Face Mask Market
13.3.2.3 Nasal Pillow/Alternative Interface Market
13.4 DRIVERS AND LIMITERS
13.4.1 Market Drivers
13.4.2 Market Limiters
13.5 COMPETITIVE MARKET SHARE ANALYSIS
14. SLEEP DIAGNOSTIC DEVICE MARKET
14.1 INTRODUCTION
14.1.1 Type I Sleep Test
14.1.2 Type II Sleep Test
14.1.3 Type III Sleep Test
14.1.4 Type IV Sleep Test
14.2 MARKET OVERVIEW
14.3 MARKET ANALYSIS AND FORECAST
14.3.1 Total Sleep Diagnostic Device Market
14.3.2 Type I Device Market
14.3.3 Type II Device Market
14.3.4 Type III Device Market
14.3.5 Type IV Device Market
14.4 DRIVERS AND LIMITERS
14.4.1 Market Drivers
14.4.2 Market Limiters
14.5 COMPETITIVE MARKET SHARE ANALYSIS
14.1.1 Type I Sleep Test
14.1.2 Type II Sleep Test
14.1.3 Type III Sleep Test
14.1.4 Type IV Sleep Test
14.2 MARKET OVERVIEW
14.3 MARKET ANALYSIS AND FORECAST
14.3.1 Total Sleep Diagnostic Device Market
14.3.2 Type I Device Market
14.3.3 Type II Device Market
14.3.4 Type III Device Market
14.3.5 Type IV Device Market
14.4 DRIVERS AND LIMITERS
14.4.1 Market Drivers
14.4.2 Market Limiters
14.5 COMPETITIVE MARKET SHARE ANALYSIS
16. APPENDIX: COMPANY PRESS RELEASES
16.1 INTRODUCTION
16.2 PRESS RELEASES
16.2.1 Chart Industries
16.2.1.1 AirSep Launches New Membrane and PSA Nitrogen Systems for On-Site Gas Generation
16.2.1.2 Chart Completes Acquisition of Hudson Products
16.2.1.3 Chart Acquires VCT Vogel
16.2.1.4 Chart Announces Executive Succession Plan
16.2.1.5 Chart announces acquisition of Hetsco
16.2.2 Dr?ger
16.2.2.1 First quarter of 2018: Dräger off to a weak start to the fiscal year
16.2.2.2 Fiscal year 2017: Dräger continues to grow and improve earnings
16.2.2.3 Dräger increases both net sales and earnings
16.2.2.4 New NIV ventilation mask with silicone sealing lip
16.2.2.5 Savina 300 Select: The turbo in the ICU
16.2.2.6 Oxylog VE300: A sturdy life saver in emergency response
16.2.2.7 Dräger acquires majority stake in Hamburg-based start-up bentekk
16.2.2.8 Fiscal year 2016: Dräger sees significant increase in earnings despite decline in net sales
16.2.3 Drive DeVilbiss Healthcare, Inc.
16.2.3.1 Drive DeVilbiss Healthcare Becomes Exclusive Distributor of the Uccello Kettle
16.2.3.2 Drive DeVilbiss Healthcare Adds New CEO to Its Leadership Team
16.2.3.3 Drive DeVilbiss 10 Liter Oxygen Concentrator Wins 2017 HME Business New Product Award
16.2.3.4 Drive DeVilbiss Healthcare Introduces the Smallest, Lightest 10 Liter Oxygen Concentrator on the Market
16.2.3.5 Drive DeVilbiss Acquires Sidhil Group Limited, The U.K.'s Leading Manufacturer of Hospital and Home Healthcare Beds
16.2.3.6 Clayton, Dubilier & Rice Makes Significant Investment in Drive DeVilbiss Healthcare in Partnership with Existing Management
16.2.4 Fisher & Paykel
16.2.4.1 New research shows significant benefits for COPD patients in the home using Fisher & Paykel Healthcare's myAirvo
16.2.4.2 Ground Breaking Research Shows Efficacy of Optiflow™ Nasal High Flow Therapy
16.2.4.3 Strong Half Year Result from Fisher & Paykel Healthcare: Record Net Profit of NZ$81.3 Million
16.2.4.4 Fisher & Paykel Healthcare wins patent case against ResMed in UK court
16.2.4.5 Pip Greenwood Appointed to Fisher & Paykel Healthcare Board
16.2.4.6 Fisher & Paykel Healthcare Reports Record Annual Result, Net Profit Up 18%
16.2.4.7 Fisher & Paykel Healthcare Launches New CPAP Device
16.2.4.8 Fisher & Paykel Healthcare Releases New Infant Cannula
16.2.4.9 Prestigious Red Dot Award for Fisher & Paykel Healthcare's New Brevida Mask
16.2.4.10 Former Employee Pleads Guilty to Charges
16.2.4.11 Fisher & Paykel Healthcare's Brevida Mask Takes Out Top Design Award
16.2.5 GE Healthcare
16.2.5.1 Veritas Capital to Acquire Revenue-Cycle, Ambulatory Care and Workforce Management Software Unit from GE Healthcare for $1 Billion
16.2.5.2 Ministry of Health and GE delivering digital solutions to bring transformative change to Kingdom’s healthcare sector
16.2.5.3 GE Healthcare and Navicent Health Enter Relationship to Reduce Costs, Improve Patient Care and Target $150 Million in Savings over Six Years
16.2.5.4 Clover Biopharmaceuticals selects GE’s FlexFactory biomanufacturing platform for its new production facility in China
16.2.5.5 Lifespan and GE Healthcare Put New Plan in Place to Reduce Care Delivery Costs by $182 Million over Six Years
16.2.5.6 GE Healthcare acquires bioprocessing start-up Puridify
16.2.5.7 GE Healthcare Receives Carequality Certification, Advancing Data Exchange with Cloud Technology
16.2.5.8 Catherine Estrampes appointed President & CEO of GE Healthcare Europe
16.2.5.9 Emmanuel Ligner named President and CEO of GE Healthcare Life Sciences
16.2.5.10 GE Healthcare Acquires Novia Strategies to expand Clinical Consulting Capabilities and Help More Healthcare Organizations Achieve Breakthrough Outcomes
16.2.5.11 Kieran Murphy Appointed CEO of GE Healthcare, Succeeding John Flannery
16.2.5.12 Partners HealthCare and GE Healthcare launch 10-year collaboration to integrate Artificial Intelligence into every aspect of the patient journey
16.2.5.13 United BioPharma selects GE Healthcare’s FlexFactory to build late-stage clinical and commercial production capacity for biopharmaceuticals
16.2.5.14 GE Healthcare acquires Asymptote for complete, digitally-enabled cryogenic cold chain technology supporting safe manufacture and delivery of cellular therapies
16.2.5.15 GE Healthcare invests in Zenith Technologies, the companies to deliver together next-generation of biopharma automation
16.2.5.16 Arven Pharmaceuticals selects GE Healthcare’s FlexFactory to improve Turkish and regional access to biopharmaceuticals
16.2.6 Invacare
16.2.6.1 Invacare Appoints Kathleen Leneghan Chief Financial Officer
16.2.6.2 Invacare Corporation Announces Financial Results for the Fourth Quarter and Full Year Ended December 31, 2017
16.2.6.3 Invacare Announces North America Reduction in Force as Part of Continued Cost Realignment
16.2.6.4 Invacare Announces Departure of Chief Financial Officer
16.2.6.5 Invacare Expands Healthcare Informatics Platform to Oxygen Technology
16.2.6.6 Invacare Corporation Appoints Barbara Bodem to Board of Directors
16.2.6.7 Invacare Corporation Announces Closure of China Manufacturing Facility in Line with Strategic Transformation
16.2.6.8 Invacare Continues Realignment as Part of Its Ongoing Transformation
16.2.6.9 Invacare Introduces ‘Outcomes by Design’ Program for Post-Acute Care Facilities
16.2.6.10 Invacare Reports Completion of Consent Decree Milestones
16.2.7 Medtronic
16.2.7.1 Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics
16.2.7.2 Medtronic and Lehigh Valley Health Network Sign Strategic Partnership Agreement Focused on Delivering Value-Based Healthcare Programs
16.2.7.3 Medtronic Reports Third Quarter Financial Results
16.2.7.4 Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region
16.2.7.5 Medtronic and Philips Partner to Innovate in Lung Cancer Management
16.2.7.6 Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region
16.2.7.7 Medtronic Releases Fiscal Year 2017 Integrated Performance Report
16.2.7.8 Medtronic Care Management Services and American Well Announce Strategic Partnership to Integrate Telehealth Capabilities
16.2.7.9 Medtronic and Mercy Announce Data Sharing Partnership to Accelerate Medical Device Innovation
16.2.7.10 Medtronic to Establish Innovation Center in Chengdu
16.2.7.11 Medtronic Completes Sale of a Portion of Its Patient Monitoring & Recovery Division to Cardinal Health
16.2.7.12 Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results
16.2.7.13 Medtronic Announces Worldwide Voluntary Field Corrective Action For Newport(TM) HT70 and Newport(TM) HT70 Plus Ventilators
16.2.7.14 New Partnership Between Medtronic and Atlas General Hospital Brings Advanced Surgical Technologies and Treatment Options to Serbia
16.2.7.15 Medtronic Announces New, Outcome-Based Learning Program
16.2.7.16 Invacare Reports Completion of Consent Decree Milestones
16.2.8 Natus
16.2.8.1 NATUS MEDICAL ANNOUNCES FIRST QUARTER FINANCIAL RESULTS
16.2.8.2 NATUS CONFIRMS RECEIPT OF NOTICE OF VOCE CAPITAL’S INTENT TO NOMINATE DIRECTOR CANDIDATES TO REPLACE 50% OF THE NATUS BOARD
16.2.8.3 NATUS ANNOUNCES $30 MILLION SHARE REPURCHASE PROGRAM
16.2.8.4 NATUS MEDICAL ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS
16.2.8.5 NATUS APPOINTS LESLIE MCDONNELL AS VICE PRESIDENT AND GENERAL MANAGER OF ITS NEWBORN CARE BUSINESS UNIT
16.2.8.6 NATUS TO BE EXCLUSIVE U.S. AGENT FOR THE FIRST NEONATAL MRI DEVICE
16.2.8.7 NATUS COMPLETES ACQUISITION OF NEUROSURGERY ASSETS FROM INTEGRA LIFESCIENCES
16.2.8.8 NATUS MEDICAL ANNOUNCES FOURTH QUARTER AND FULL YEAR 2016 FINANCIAL RESULTS
16.2.8.9 NATUS COMPLETES ACQUISITION OF GN OTOMETRICS BUSINESS
16.2.9 Omron
16.2.9.1 OMRON's Fiscal 2017 Net Income Jumps 37.3%, to Record JPY63.2 Billion
16.2.9.2 "Near-future designs": OMRON's challenge for the future - OMRON establishes OMRON SINIC X Corporation
16.2.9.3 Notice Regarding the status (Progress Report) of Acquisition of Treasury Stock
16.2.9.4 OMRON Announces the Establishment of OMRON EXPERTLINK Co., Ltd.
16.2.9.5 Directors, Auditors and Executive Officers Changes
16.2.9.6 Announcing the Founding of the Edgecross Consortium
16.2.9.7 OMRON Completes Acquisition of Microscan Systems
16.2.9.8 OMRON Completes Acquisition of Sentech
16.2.9.9 Personnel changes
16.2.9.10 Executive Officer Changes of Affiliated Company
16.2.9.11 OMRON, RIKEN Agree to Set up RBOmC, Cooperate in Comprehensive Collaboration
16.2.9.12 Personnel changes
16.2.9.13 Notice regarding Capital and Business Partnerships with AliveCor
16.2.9.14 Executive Officer Changes of Affiliated Company
16.2.9.15 OMRON Announces Change of Representative Directors
16.2.9.16 Directors, Auditors and Executive Officers Changes
16.2.9.17 OMRON opens regional head office in South Korea
16.2.10 Philips
16.2.10.1 Philips and Samsung team up to expand the connected health ecosystem
16.2.10.2 Saratoga Hospital partners with Philips to improve patient care and safety
16.2.10.3 Northwell Health improves patient care and satisfaction with Philips integrated patient monitoring solutions
16.2.10.4 Philips launches AI platform for healthcare
16.2.10.5 Philips launches FocusPoint, an intuitive web-based application to help reduce costs and improve operational efficiencies
16.2.10.6 Philips debuts fully integrated suite of enhanced patient monitoring solutions in U.S. market
16.2.10.7 Vitor Rocha succeeds Brent Shafer as CEO of Philips North America
16.2.10.8 Philips teams with 3D printing industry leaders 3D Systems and Stratasys
16.2.10.9 Philips announces agreement with Lakeland Health for advanced monitoring to improve patient safety
16.2.10.10 Philips launches cloud-connected Trilogy in North America
16.2.10.11 Philips adds Pillows cushion option to award-winning DreamWear mask line
16.2.10.12 Philips-sponsored study suggests positive airway pressure therapy could reduce COPD patient hospitalization
16.2.10.13 Philips simplifies travel for sleep apnea patients with new compact and connected DreamStation Go sleep therapy device
16.2.10.14 Philips and Phoenix Children’s Hospital sign 15-year agreement to redefine imaging, patient monitoring and clinical informatics in pediatric care
16.2.10.15 Philips IntelliSpace Perinatal named 2017 KLAS Category Leader for Labor and Delivery Software
16.2.10.16 Philips launches IntelliSpace Enterprise Edition, an industry-first managed service for hospital-wide healthcare informatics
16.2.10.17 Philips receives FDA 510(k) clearance to market the next-generation of IntelliVue Guardian Solution to aid clinicians in identifying potential signs of early patient deterioration
16.2.11 ResMed
16.2.11.1 ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2018
16.2.11.2 ATS Foundation and ResMed Announce Two-Year Research Grant in Sleep-Disordered Breathing
16.2.11.3 SleepScore Labs Acquires Sleep.ai
16.2.11.4 ResMed Hires Bobby Ghoshal as First Chief Technology Officer
16.2.11.5 ResMed Joins MedTech Europe
16.2.11.6 VGM & Associates Extends Its Membership Agreement with Brightree
16.2.11.7 SleepScore Labs Launches First Sleep Ecosystem Leveraging Accurate Big Data
16.2.11.8 ResMed Announces Its Premier Portable Oxygen Concentrator, Mobi
16.2.11.9 SleepScore Announces Exclusive Retail Partnership with Williams-Sonoma, Inc.
16.2.11.10 ResMed Elects Karen Drexler to Its Board of Directors
16.2.11.11 Statement by ResMed on United Kingdom Case with Fisher & Paykel
16.2.11.12 SleepScore Labs Launches the World's Most Advanced Sleep Improvement System
16.2.11.13 ResMed Adds Remote Patient Monitoring to AirMini, World's Smallest CPAP
16.2.11.14 ResMed AirFit N20 Classic CPAP Mask Launches in Europe
16.2.11.15 Brightree Appoints Robert Dean to Lead Home Health & Hospice Division
16.2.11.16 ResMed Wins German Patent Infringement Case Brought by Fisher & Paykel
16.2.11.17 ResMed's European Patents Infringed by Fisher & Paykel in Germany
16.2.11.18 Automated Resupply Enrollment Now Available for HMEs Using Brightree and ResMed’s AirView
16.2.11.19 ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2017
16.2.11.20 Brightree Acquires AllCall Connect for Expanded CPAP Resupply Capabilities and Better Patient Care
16.2.11.21 ResMed Awarded Best Design for “Game-changing” CPAP, CPAP Masks
16.2.11.22 Brightree Acquires Conduit Technology, LLC
16.2.11.23 World’s Smallest CPAP, ResMed’s AirMini, Now Shipping to HMEs
16.2.11.24 Introducing the Softest CPAP Mask from ResMed
16.2.11.25 ResMed Unveils AirMini - the World's Smallest CPAP
16.2.11.26 ATS Foundation Announces $100,000, Two-year Non-Invasive Ventilation Research Grant
16.2.11.27 Brightree Expands Sleep Therapy Capabilities with ResMed’s AirView Platform
16.2.11.28 ResMed and BMC/3B Medical Settle Global Litigation
16.2.11.29 ResMed's myAir™ Significantly Improves Adherence to CPAP Therapy in Patients with Sleep Apnea
16.2.11.30 FDA Clears World's Smallest CPAP, ResMed AirMini™
16.2.11.31 Dr. Oz, ResMed Launch SleepScore Labs - Promising the World a Better Night's Sleep
16.2.12 Teleflex
16.2.12.1 Teleflex Reports First Quarter 2018 Results
16.2.12.2 Teleflex Reports Fourth Quarter and Full Year 2017 Results; Provides 2018 Guidance
16.2.12.3 Teleflex Completes Previously Announced CEO Transition
16.2.12.4 Teleflex Signs New Agreement with HealthTrust for Respiratory Heaters & Accessories
16.2.12.5 Teleflex Receives Innovative Technology Designation from Vizient for LMA® Gastro™ Airway
16.2.12.6 Teleflex Receives Innovative Technology Designation from Vizient for LMA® Gastro™ Airway
16.2.12.7 Teleflex Incorporated Completes Acquisition of NeoTract
16.2.12.8 Teleflex Completes Acquisition of Pyng Medical Corp.
16.2.12.9 Teleflex Incorporated Announces Benson Smith to Retire as Chief Executive Officer at End of 2017; Liam Kelly to Succeed Smith as Chief Executive Officer
16.2.12.10 Teleflex Incorporated Completes Acquisition of Vascular Solutions
16.2.12.11 Teleflex Launches the LMA® Gastro™ Airway for Airway Management During Endoscopic Procedures
16.2.13 Vyaire Medical
16.2.13.1 Vyaire Medical executes on its plan to become a global leader in respiratory care
16.2.13.2 Vyaire Medical Acquires Revolutionary Medical Devices, Inc.
16.2.13.3 Vyaire Medical Acquires Ciel Medical
16.2 PRESS RELEASES
16.2.1 Chart Industries
16.2.1.1 AirSep Launches New Membrane and PSA Nitrogen Systems for On-Site Gas Generation
16.2.1.2 Chart Completes Acquisition of Hudson Products
16.2.1.3 Chart Acquires VCT Vogel
16.2.1.4 Chart Announces Executive Succession Plan
16.2.1.5 Chart announces acquisition of Hetsco
16.2.2 Dr?ger
16.2.2.1 First quarter of 2018: Dräger off to a weak start to the fiscal year
16.2.2.2 Fiscal year 2017: Dräger continues to grow and improve earnings
16.2.2.3 Dräger increases both net sales and earnings
16.2.2.4 New NIV ventilation mask with silicone sealing lip
16.2.2.5 Savina 300 Select: The turbo in the ICU
16.2.2.6 Oxylog VE300: A sturdy life saver in emergency response
16.2.2.7 Dräger acquires majority stake in Hamburg-based start-up bentekk
16.2.2.8 Fiscal year 2016: Dräger sees significant increase in earnings despite decline in net sales
16.2.3 Drive DeVilbiss Healthcare, Inc.
16.2.3.1 Drive DeVilbiss Healthcare Becomes Exclusive Distributor of the Uccello Kettle
16.2.3.2 Drive DeVilbiss Healthcare Adds New CEO to Its Leadership Team
16.2.3.3 Drive DeVilbiss 10 Liter Oxygen Concentrator Wins 2017 HME Business New Product Award
16.2.3.4 Drive DeVilbiss Healthcare Introduces the Smallest, Lightest 10 Liter Oxygen Concentrator on the Market
16.2.3.5 Drive DeVilbiss Acquires Sidhil Group Limited, The U.K.'s Leading Manufacturer of Hospital and Home Healthcare Beds
16.2.3.6 Clayton, Dubilier & Rice Makes Significant Investment in Drive DeVilbiss Healthcare in Partnership with Existing Management
16.2.4 Fisher & Paykel
16.2.4.1 New research shows significant benefits for COPD patients in the home using Fisher & Paykel Healthcare's myAirvo
16.2.4.2 Ground Breaking Research Shows Efficacy of Optiflow™ Nasal High Flow Therapy
16.2.4.3 Strong Half Year Result from Fisher & Paykel Healthcare: Record Net Profit of NZ$81.3 Million
16.2.4.4 Fisher & Paykel Healthcare wins patent case against ResMed in UK court
16.2.4.5 Pip Greenwood Appointed to Fisher & Paykel Healthcare Board
16.2.4.6 Fisher & Paykel Healthcare Reports Record Annual Result, Net Profit Up 18%
16.2.4.7 Fisher & Paykel Healthcare Launches New CPAP Device
16.2.4.8 Fisher & Paykel Healthcare Releases New Infant Cannula
16.2.4.9 Prestigious Red Dot Award for Fisher & Paykel Healthcare's New Brevida Mask
16.2.4.10 Former Employee Pleads Guilty to Charges
16.2.4.11 Fisher & Paykel Healthcare's Brevida Mask Takes Out Top Design Award
16.2.5 GE Healthcare
16.2.5.1 Veritas Capital to Acquire Revenue-Cycle, Ambulatory Care and Workforce Management Software Unit from GE Healthcare for $1 Billion
16.2.5.2 Ministry of Health and GE delivering digital solutions to bring transformative change to Kingdom’s healthcare sector
16.2.5.3 GE Healthcare and Navicent Health Enter Relationship to Reduce Costs, Improve Patient Care and Target $150 Million in Savings over Six Years
16.2.5.4 Clover Biopharmaceuticals selects GE’s FlexFactory biomanufacturing platform for its new production facility in China
16.2.5.5 Lifespan and GE Healthcare Put New Plan in Place to Reduce Care Delivery Costs by $182 Million over Six Years
16.2.5.6 GE Healthcare acquires bioprocessing start-up Puridify
16.2.5.7 GE Healthcare Receives Carequality Certification, Advancing Data Exchange with Cloud Technology
16.2.5.8 Catherine Estrampes appointed President & CEO of GE Healthcare Europe
16.2.5.9 Emmanuel Ligner named President and CEO of GE Healthcare Life Sciences
16.2.5.10 GE Healthcare Acquires Novia Strategies to expand Clinical Consulting Capabilities and Help More Healthcare Organizations Achieve Breakthrough Outcomes
16.2.5.11 Kieran Murphy Appointed CEO of GE Healthcare, Succeeding John Flannery
16.2.5.12 Partners HealthCare and GE Healthcare launch 10-year collaboration to integrate Artificial Intelligence into every aspect of the patient journey
16.2.5.13 United BioPharma selects GE Healthcare’s FlexFactory to build late-stage clinical and commercial production capacity for biopharmaceuticals
16.2.5.14 GE Healthcare acquires Asymptote for complete, digitally-enabled cryogenic cold chain technology supporting safe manufacture and delivery of cellular therapies
16.2.5.15 GE Healthcare invests in Zenith Technologies, the companies to deliver together next-generation of biopharma automation
16.2.5.16 Arven Pharmaceuticals selects GE Healthcare’s FlexFactory to improve Turkish and regional access to biopharmaceuticals
16.2.6 Invacare
16.2.6.1 Invacare Appoints Kathleen Leneghan Chief Financial Officer
16.2.6.2 Invacare Corporation Announces Financial Results for the Fourth Quarter and Full Year Ended December 31, 2017
16.2.6.3 Invacare Announces North America Reduction in Force as Part of Continued Cost Realignment
16.2.6.4 Invacare Announces Departure of Chief Financial Officer
16.2.6.5 Invacare Expands Healthcare Informatics Platform to Oxygen Technology
16.2.6.6 Invacare Corporation Appoints Barbara Bodem to Board of Directors
16.2.6.7 Invacare Corporation Announces Closure of China Manufacturing Facility in Line with Strategic Transformation
16.2.6.8 Invacare Continues Realignment as Part of Its Ongoing Transformation
16.2.6.9 Invacare Introduces ‘Outcomes by Design’ Program for Post-Acute Care Facilities
16.2.6.10 Invacare Reports Completion of Consent Decree Milestones
16.2.7 Medtronic
16.2.7.1 Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics
16.2.7.2 Medtronic and Lehigh Valley Health Network Sign Strategic Partnership Agreement Focused on Delivering Value-Based Healthcare Programs
16.2.7.3 Medtronic Reports Third Quarter Financial Results
16.2.7.4 Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region
16.2.7.5 Medtronic and Philips Partner to Innovate in Lung Cancer Management
16.2.7.6 Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region
16.2.7.7 Medtronic Releases Fiscal Year 2017 Integrated Performance Report
16.2.7.8 Medtronic Care Management Services and American Well Announce Strategic Partnership to Integrate Telehealth Capabilities
16.2.7.9 Medtronic and Mercy Announce Data Sharing Partnership to Accelerate Medical Device Innovation
16.2.7.10 Medtronic to Establish Innovation Center in Chengdu
16.2.7.11 Medtronic Completes Sale of a Portion of Its Patient Monitoring & Recovery Division to Cardinal Health
16.2.7.12 Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results
16.2.7.13 Medtronic Announces Worldwide Voluntary Field Corrective Action For Newport(TM) HT70 and Newport(TM) HT70 Plus Ventilators
16.2.7.14 New Partnership Between Medtronic and Atlas General Hospital Brings Advanced Surgical Technologies and Treatment Options to Serbia
16.2.7.15 Medtronic Announces New, Outcome-Based Learning Program
16.2.7.16 Invacare Reports Completion of Consent Decree Milestones
16.2.8 Natus
16.2.8.1 NATUS MEDICAL ANNOUNCES FIRST QUARTER FINANCIAL RESULTS
16.2.8.2 NATUS CONFIRMS RECEIPT OF NOTICE OF VOCE CAPITAL’S INTENT TO NOMINATE DIRECTOR CANDIDATES TO REPLACE 50% OF THE NATUS BOARD
16.2.8.3 NATUS ANNOUNCES $30 MILLION SHARE REPURCHASE PROGRAM
16.2.8.4 NATUS MEDICAL ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS
16.2.8.5 NATUS APPOINTS LESLIE MCDONNELL AS VICE PRESIDENT AND GENERAL MANAGER OF ITS NEWBORN CARE BUSINESS UNIT
16.2.8.6 NATUS TO BE EXCLUSIVE U.S. AGENT FOR THE FIRST NEONATAL MRI DEVICE
16.2.8.7 NATUS COMPLETES ACQUISITION OF NEUROSURGERY ASSETS FROM INTEGRA LIFESCIENCES
16.2.8.8 NATUS MEDICAL ANNOUNCES FOURTH QUARTER AND FULL YEAR 2016 FINANCIAL RESULTS
16.2.8.9 NATUS COMPLETES ACQUISITION OF GN OTOMETRICS BUSINESS
16.2.9 Omron
16.2.9.1 OMRON's Fiscal 2017 Net Income Jumps 37.3%, to Record JPY63.2 Billion
16.2.9.2 "Near-future designs": OMRON's challenge for the future - OMRON establishes OMRON SINIC X Corporation
16.2.9.3 Notice Regarding the status (Progress Report) of Acquisition of Treasury Stock
16.2.9.4 OMRON Announces the Establishment of OMRON EXPERTLINK Co., Ltd.
16.2.9.5 Directors, Auditors and Executive Officers Changes
16.2.9.6 Announcing the Founding of the Edgecross Consortium
16.2.9.7 OMRON Completes Acquisition of Microscan Systems
16.2.9.8 OMRON Completes Acquisition of Sentech
16.2.9.9 Personnel changes
16.2.9.10 Executive Officer Changes of Affiliated Company
16.2.9.11 OMRON, RIKEN Agree to Set up RBOmC, Cooperate in Comprehensive Collaboration
16.2.9.12 Personnel changes
16.2.9.13 Notice regarding Capital and Business Partnerships with AliveCor
16.2.9.14 Executive Officer Changes of Affiliated Company
16.2.9.15 OMRON Announces Change of Representative Directors
16.2.9.16 Directors, Auditors and Executive Officers Changes
16.2.9.17 OMRON opens regional head office in South Korea
16.2.10 Philips
16.2.10.1 Philips and Samsung team up to expand the connected health ecosystem
16.2.10.2 Saratoga Hospital partners with Philips to improve patient care and safety
16.2.10.3 Northwell Health improves patient care and satisfaction with Philips integrated patient monitoring solutions
16.2.10.4 Philips launches AI platform for healthcare
16.2.10.5 Philips launches FocusPoint, an intuitive web-based application to help reduce costs and improve operational efficiencies
16.2.10.6 Philips debuts fully integrated suite of enhanced patient monitoring solutions in U.S. market
16.2.10.7 Vitor Rocha succeeds Brent Shafer as CEO of Philips North America
16.2.10.8 Philips teams with 3D printing industry leaders 3D Systems and Stratasys
16.2.10.9 Philips announces agreement with Lakeland Health for advanced monitoring to improve patient safety
16.2.10.10 Philips launches cloud-connected Trilogy in North America
16.2.10.11 Philips adds Pillows cushion option to award-winning DreamWear mask line
16.2.10.12 Philips-sponsored study suggests positive airway pressure therapy could reduce COPD patient hospitalization
16.2.10.13 Philips simplifies travel for sleep apnea patients with new compact and connected DreamStation Go sleep therapy device
16.2.10.14 Philips and Phoenix Children’s Hospital sign 15-year agreement to redefine imaging, patient monitoring and clinical informatics in pediatric care
16.2.10.15 Philips IntelliSpace Perinatal named 2017 KLAS Category Leader for Labor and Delivery Software
16.2.10.16 Philips launches IntelliSpace Enterprise Edition, an industry-first managed service for hospital-wide healthcare informatics
16.2.10.17 Philips receives FDA 510(k) clearance to market the next-generation of IntelliVue Guardian Solution to aid clinicians in identifying potential signs of early patient deterioration
16.2.11 ResMed
16.2.11.1 ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2018
16.2.11.2 ATS Foundation and ResMed Announce Two-Year Research Grant in Sleep-Disordered Breathing
16.2.11.3 SleepScore Labs Acquires Sleep.ai
16.2.11.4 ResMed Hires Bobby Ghoshal as First Chief Technology Officer
16.2.11.5 ResMed Joins MedTech Europe
16.2.11.6 VGM & Associates Extends Its Membership Agreement with Brightree
16.2.11.7 SleepScore Labs Launches First Sleep Ecosystem Leveraging Accurate Big Data
16.2.11.8 ResMed Announces Its Premier Portable Oxygen Concentrator, Mobi
16.2.11.9 SleepScore Announces Exclusive Retail Partnership with Williams-Sonoma, Inc.
16.2.11.10 ResMed Elects Karen Drexler to Its Board of Directors
16.2.11.11 Statement by ResMed on United Kingdom Case with Fisher & Paykel
16.2.11.12 SleepScore Labs Launches the World's Most Advanced Sleep Improvement System
16.2.11.13 ResMed Adds Remote Patient Monitoring to AirMini, World's Smallest CPAP
16.2.11.14 ResMed AirFit N20 Classic CPAP Mask Launches in Europe
16.2.11.15 Brightree Appoints Robert Dean to Lead Home Health & Hospice Division
16.2.11.16 ResMed Wins German Patent Infringement Case Brought by Fisher & Paykel
16.2.11.17 ResMed's European Patents Infringed by Fisher & Paykel in Germany
16.2.11.18 Automated Resupply Enrollment Now Available for HMEs Using Brightree and ResMed’s AirView
16.2.11.19 ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2017
16.2.11.20 Brightree Acquires AllCall Connect for Expanded CPAP Resupply Capabilities and Better Patient Care
16.2.11.21 ResMed Awarded Best Design for “Game-changing” CPAP, CPAP Masks
16.2.11.22 Brightree Acquires Conduit Technology, LLC
16.2.11.23 World’s Smallest CPAP, ResMed’s AirMini, Now Shipping to HMEs
16.2.11.24 Introducing the Softest CPAP Mask from ResMed
16.2.11.25 ResMed Unveils AirMini - the World's Smallest CPAP
16.2.11.26 ATS Foundation Announces $100,000, Two-year Non-Invasive Ventilation Research Grant
16.2.11.27 Brightree Expands Sleep Therapy Capabilities with ResMed’s AirView Platform
16.2.11.28 ResMed and BMC/3B Medical Settle Global Litigation
16.2.11.29 ResMed's myAir™ Significantly Improves Adherence to CPAP Therapy in Patients with Sleep Apnea
16.2.11.30 FDA Clears World's Smallest CPAP, ResMed AirMini™
16.2.11.31 Dr. Oz, ResMed Launch SleepScore Labs - Promising the World a Better Night's Sleep
16.2.12 Teleflex
16.2.12.1 Teleflex Reports First Quarter 2018 Results
16.2.12.2 Teleflex Reports Fourth Quarter and Full Year 2017 Results; Provides 2018 Guidance
16.2.12.3 Teleflex Completes Previously Announced CEO Transition
16.2.12.4 Teleflex Signs New Agreement with HealthTrust for Respiratory Heaters & Accessories
16.2.12.5 Teleflex Receives Innovative Technology Designation from Vizient for LMA® Gastro™ Airway
16.2.12.6 Teleflex Receives Innovative Technology Designation from Vizient for LMA® Gastro™ Airway
16.2.12.7 Teleflex Incorporated Completes Acquisition of NeoTract
16.2.12.8 Teleflex Completes Acquisition of Pyng Medical Corp.
16.2.12.9 Teleflex Incorporated Announces Benson Smith to Retire as Chief Executive Officer at End of 2017; Liam Kelly to Succeed Smith as Chief Executive Officer
16.2.12.10 Teleflex Incorporated Completes Acquisition of Vascular Solutions
16.2.12.11 Teleflex Launches the LMA® Gastro™ Airway for Airway Management During Endoscopic Procedures
16.2.13 Vyaire Medical
16.2.13.1 Vyaire Medical executes on its plan to become a global leader in respiratory care
16.2.13.2 Vyaire Medical Acquires Revolutionary Medical Devices, Inc.
16.2.13.3 Vyaire Medical Acquires Ciel Medical
Companies mentioned
- Philips
- ResMed
- CAIRE
- GE Healthcare
- Medtronic
- DeVilbiss
- VyAire
- Fisher & Paykel
- Invacare
- Teleflex
- Dräger
- Others include: Advanced Brain Monitoring, Aerogen, Airgas, Braebon Medical, Cadwell Labs, Catalina Cylinders, CleveMed, ConvaTec, Cramer Decker, eVent, Flexicare, Flotec, Fukuda Denshi, Graham Field, IBM Watson Health, iMDsoft, , Luxfer, Mada Medical, Maquet, Masimo, Medline, Mercury Medical, Metal Impact, NovaSom, Nidek, Nihon Kohden, O2 Concepts, PARI, Penlon, Percussionaire, Picis, Precision Medical, Salter Labs, Sechrist, Somnetics, Somnomed, SOMNOomedics, Spacelabs, SunMed, The Respiratory Group, Ventlab, Welch Allyn, WestMed, Worthington, Zoll.
